Nicolau et al. [21] introduce a topological method that identifies a unique subgroup of estrogen receptor-positive (ER+) breast cancers that express high levels of c-MYB and low levels of innate inflammatory genes. The gene discussed is ESR1; the disease is breast carcinoma.